US 6415170

I'll search for this specific patent in the USPTO database and check the CAFC 2026 dockets for any proceedings involving it.

Let me run additional searches to confirm the legal status and check for any CAFC proceedings more specifically.

Summary of U.S. Patent No. 6,415,170 (US6415170B1)

Search results note: No CAFC 2026 docket entries or any Federal Circuit appeal referencing this patent were located in my searches. The USPTO/Google Patents record shows the patent expired in 2010 for failure to pay maintenance fees (lapsed effective 2010-07-02), which is consistent with the "Expired – Fee Related" status shown on the record. I found no post-grant proceedings (IPR/CBM) or litigation naming 6,415,170 in the searched sources.

Bibliographic data (verified against Google Patents record)

• Title: Biomedical electrode and method for its manufacture
• Assignee: 3M Innovative Properties Co. (originally filed by Minnesota Mining and Manufacturing Company; assigned to 3M Innovative Properties Co. in 2002)
• Inventors: Nikolaus Loutis; Derek Wright; Paul Wiedenhaupt
• Application No.: 09/214,878 (PCT/US1997/012124, national stage)
• Filing date: 1997-07-14
• Priority date: 1996-12-09 (claimed from GB 9625533.6, filed 1996-12-09)
• Issue date: 2002-07-02
• Legal status: Expired – Fee Related (lapsed 2010 due to nonpayment of maintenance fees)

Abstract

A biomedical electrode comprises a connector stud (1) anchored in a patch of adhesive-coated backing material (7) used to secure the electrode to the skin of a patient. The connector stud (1), located in a pierced opening in the backing material (7), has a head portion (2) to which an electrical lead of an electromedical monitoring/diagnostic system can be attached, and an electrode plate (3) which, in use, is placed in electrical communication with the patient's skin. A strip of ionically-conductive adhesive (9) extends across the backing material and over the electrode plate (3), and a strip of scrim material (17) is located adjacent the adhesive coating on the backing material, underneath the adhesive strip (9). The two strips (9, 17) are displaced, relative to the electrode plate (3), toward a tab (13) used for removing the electrode from the skin.

Plain-language overview of independent claims

The patent has 29 claims; the independent claims are 1, 3, 5, 7, 19, and 22 (the remainder are dependent).

• Claim 1 (electrode): A biomedical electrode having (a) a backing material coated on one side with a pressure-sensitive adhesive and having a non-adhesive margin for handling; (b) a connector stud in the backing material, with an electrode plate on the adhesive side (for skin contact) and a head portion on the opposite side (for attaching an electrical connector); (c) a strip of ionically-conductive adhesive running parallel to the non-adhesive margin, edge-to-edge across the adhesive side and over the electrode plate; and (d) a parallel strip of scrim at the interface between the two adhesives, displaced toward the non-adhesive margin such that the nearest edges of both strips sit to one side of the electrode plate. In short: a tabbed ECG/EEG patch electrode whose conductive-adhesive and scrim strips are offset toward the pull-tab side of the plate.

• Claim 3 (method): Manufacturing a biomedical electrode by providing a connector stud (electrode plate + head portion), inserting it into a pierced opening in a backing material so the plate and head are on opposite sides, and providing a scrim strip located to one side of the center of the electrode plate on the first side of the backing material.

• Claim 5 (method): A manufacturing variant that forms an opening in the backing material, inserts a tubular member through the opening from one side, then places the stud head-first into the end of the tubular member from the other side (i.e., a sleeve-assisted insertion technique), again providing a scrim strip offset to one side of the electrode plate's center. (Dependent claim 6 specifies the opening may be punched rather than pierced.)

• Claim 7 (electrode): Similar to claim 1, but the ionically-conductive adhesive strip itself is expressly recited as displaced toward the non-adhesive margin (rather than merely the scrim), and the "from edge to edge" language is omitted; both strips' nearest edges are still positioned to one side of the electrode plate.

• Claim 19 (electrode): Similar to claim 1 with the scrim located to one side of the center of the electrode plate.

• Claim 22 (electrode): Adds that the scrim strip extends between the pressure-sensitive adhesive and the electrode plate of the stud — i.e., the scrim is interposed in the gap region adjacent the plate to reinforce the bond.

Uncertainty notes

• I could not confirm any CAFC (or other court) case involving patent 6,415,170; my searches for CAFC 2026 docket entries returned no results. Given the patent lapsed in 2010, any active 2026 litigation would be unexpected, but absence from search results is not a definitive negative.
• The bibliographic details above match the Google Patents record supplied and general patent databases (FreePatentsOnline); I did not independently verify the USPTO Patent Center assignment page beyond those sources.
• Note the Google Patents record lists an internal inconsistency common to OCR'd text: claim 3 is labeled "A method ... comprising" (correct) but the claims list header in the fetched text is garbled in places (e.g., "3. A method..." appears to have dropped its claim number formatting). The substantive claim text quoted above is taken from the authoritative claims section.

Based on my searches, I found no known litigation involving US Patent 6,415,170 (US6415170B1, "Biomedical electrode and method for its manufacture").

Summary of findings

Additional context relevant to enforceability

The patent's own legal-status record shows it lapsed for failure to pay maintenance fees, effective July 2, 2010 (event codes: LAPS on 2010-07-02, FP "Lapsed due to failure to pay maintenance fee" recorded 2010-08-24). The Google Patents status field also lists the patent as "Expired – Fee Related." This substantially predates today's date (April 26, 2026), meaning the patent is no longer enforceable, which may explain the absence of any active or recent litigation.

Caveats on search scope

• My web searches for exact identifiers — "6415170", "US6415170", "6,415,170" — combined with litigation terms returned no case dockets, CAFC opinions, PACER entries, Unified Patents caselist entries, or district-court filings.
• Results that did surface (e.g., freepatentsonline references to U.S. Patent Nos. 9,662,024 and 8,473,025) are related biomedical-electrode patents, not litigation involving 6,415,170.
• I could not access PACER, the Unified Patents portal caselist, or DocketNavigator directly within this session to run a definitive docket search. If you need absolute certainty, I recommend checking:
  • https://portal.unifiedpatents.com/litigation/caselist (search "6415170")
  • PACER (federal district court dockets)
  • The CAFC opinions database
  • RPX or LexisNexis/ Westlaw litigation dockets

Conclusion: To the best of the information retrievable, no known litigation involves US Patent 6,415,170, consistent with its lapse and expiry roughly 16 years ago.

Proceedings overview

Zero AIA trial proceedings are on file for US 6415170. The USPTO Open Data Portal (ODP) ingest returns no IPR/PGR/CBM petitions against this patent, and web searches for the patent number in combination with "inter partes review," "PTAB," "IPR," "PGR," and "covered business method" surface no petition, institution decision, Final Written Decision, or Federal Circuit appeal. There is nothing to defend against or to leverage: no claims canceled, no claims sustained by the PTAB, no settlements, and no estoppel running against any petitioner. The bottom-line defensive posture is that the patent is not merely untested before the PTAB — it has been dead at the USPTO since 2010, having lapsed for nonpayment of maintenance fees on 2010-07-02 (before the AIA trial regime even opened in September 2012). Any assertion of this patent today faces a fundamental threshold problem that has nothing to do with IPR: the patent is expired/lapsed and unenforceable for past conduct only within the usual limits of 35 U.S.C. § 286.

Per-proceeding detail

No proceedings exist, so the most-impactful-first structure is inapplicable. For completeness, the closest relevant history on file is the patent's own life-cycle (not a PTAB proceeding):

Underlying patent status — US 6415170B1 ("Biomedical electrode and method for its manufacture")

• Assignee / Patent Owner: 3M Innovative Properties Co. (orig. Minnesota Mining and Manufacturing Co.; assignment recorded 1999-05-03 and 2002-02-26)
• Filed: 1997-07-14 (PCT/US1997/012124; priority claimed from GB 9625533.6, filed 1996-12-09)
• Granted: 2002-07-02
• Term/lapse: Maintenance fee paid 2006-01-03 (year 4); reminder mailed 2010-02-08; lapsed for failure to pay maintenance fees effective 2010-07-02 (USPTO legal-event codes: LAPS, "PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362," FP)
• Anticipated expiration (had it been maintained): 2017-07-14
• Status gloss: Expired — Fee Related (Google Patents), i.e., dead more than a decade before today's date (2026-09-09)
• Claims: 29 claims (independent claims 1, 7, 19, 22; method claims 3–6; apparatus claims 2, 8–18, 20–21, 23–29)

Defensive value: Not an IPR data point, but the decisive one. No petitioner has ever needed to file an IPR because the patent has not been in force since 2010. A defendant facing a demand letter citing US 6415170 should first verify whether the asserted claims correspond to a genuine pre-lapse cause of action (pre-2010 conduct, within the six-year damages window) — for any post-lapse conduct, the patent is unenforceable as a matter of law, and an infringement suit on it is subject to dismissal on pleading/statute grounds independent of any PTAB challenge.

Strategic summary

Claims status: CANCELED — none; SUSTAINED — none (by the PTAB); UNTESTED — all 29 claims. No AIA proceeding has ever been instituted on US 6415170, so no claim has been through a PTAB trial, no FWD exists, and every claim retains whatever validity posture it had when the patent lapsed in 2010. Because the patent expired by nonpayment before the AIA's post-grant trial provisions took effect, the absence of IPRs is expected rather than a signal of weakness: AIA petitions generally require a real controversy and an in-force (or at least not-yet-lapsed) patent to be worth the cost, and this patent's maintenance-fee lapse in 2010 predates the first available IPR filing window by roughly two years.

Estoppel landscape — § 315(e)(2) is a non-factor. With no petitioner, there is no estoppel running against anyone, and no prior-art ground has been "used up" in a PTAB trial. A defendant sued today would not face § 315(e)(2) bars from any prior IPR. The practical consequence is that all § 102/§ 103 patent-and-printed-publication grounds remain available in district court (subject to the separate problem that the patent's lapse makes validity largely academic for post-2010 conduct). Conversely, a defendant gains nothing from a "this claim survived IPR" or "this claim was canceled in IPR" argument — neither event occurred.

Pattern signals — none. There is no repeat petitioner, no Unified Patents or other defensive-aggregator chain, and no PTAB appeal history by the patent owner (3M) on this patent. The patent family itself shows 3M continuing to file follow-on electrode cases into the PTAB era (e.g., later 3M-owned patents such as US 10,639,827 and related family members were the subject of later prosecution), but those are different patents and are not AIA trials on 6415170.

Recommended next steps

1. Do not frame a defense around IPR. There is no IPR history to cite, and filing an IPR on a patent that lapsed in 2010 is not a viable strategy — the PTAB's trial rules and the absence of an in-force patent make such a petition a poor vehicle (and the § 315(b) one-year bar and standing requirements would need close scrutiny even in the unlikely event of a pre-2010 suit). Verify lapsed status directly: the USPTO Patent Center / assignment records and the Google Patents legal-event log for US 6415170B1 document the 2010-07-02 lapse ("PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362").

2. If you are being asserted against today, attack enforceability, not validity. Move to dismiss or for judgment on the pleadings on the ground that the patent expired for nonpayment of maintenance fees on 2010-07-02 (no petition to revive was ever granted on this record), so no post-2010 act can infringe. Confirm the asserted claim numbers and the accused conduct dates — if the demand covers only post-lapse activity, there is no viable infringement theory, and threatening an IPR would be noise.

3. Preserve validity arguments in the alternative. Because no IPR has run, no § 315(e)(2) estoppel attaches. If the patent owner somehow asserts a pre-2010 cause of action, the full universe of § 102/§ 103 prior art (including the art cited during prosecution — e.g., US 4,352,359; US 4,640,289; US 4,721,881; US 4,382,878; EP 0,142,372; EP 0,276,661; EP 0,360,496; US 5,215,087; US 5,406,945; WO 93/00857) remains available in district court. But realistically: the patent has been dead since 2010 — the correct first move is a lapsed-patent dismissal, not a PTAB petition.

Search verification note: USPTO ODP reports no AIA trials for this patent as of the most recent ingest, and targeted web searches (patent number + PTAB/IPR/PGR/CBM terms, including site-restricted USPTO queries) returned no petition or decision referencing US 6415170. I found no older or recently filed proceeding that the ODP has not yet indexed. If you are aware of a specific proceeding number, I can pull its docket from PTAB E2E and verify.

The targeted searches returned no results. Let me try other approaches to verify the assignment record.

I was unable to pull the USPTO Assignment Center's correspondent-of-record fields directly in this session (the Assignment Center UI and its underlying APIs were not reachable through the tools available, and the targeted reel/frame searches returned no additional detail). The assignment record below therefore rests on the USPTO-sourced legal-event data embedded in Google Patents (which mirrors the Assignment Center reel/frame entries) plus the issued patent and PCT family record. I flag correspondent fields as unverified rather than invent them.

Inventors

• Nikolaus Loutis — employer at filing not independently documented in accessible sources; assigned all rights to Minnesota Mining and Manufacturing Company (3M), consistent with a 3M employee relationship. Name and the UK priority filing (GB 9625533.6, filed 1996-12-09) suggest 3M United Kingdom.
• Derek Wright — same pattern as Loutis: assignment to 3M; UK priority chain suggests 3M United Kingdom employment.
• Paul Wiedenhaupt — same pattern: assignment to 3M; likely US-based 3M employee.

Unusual pattern check: no evidence of mass inventor departure or pre-sale portfolio behavior — this is a routine employee-to-employer assignment recorded ~17 months after the PCT filing date (recorded 1999-05-03, effective 1999-01-04).

Original assignee

• Minnesota Mining and Manufacturing Company (3M) — named on the issued patent via the recorded assignments; the patent front page shows 3M Innovative Properties Co. as assignee, which is 3M's captive intellectual-property holding subsidiary.
• Product embodiment: Yes — the specification itself cites 3M's commercial Red Dot™ biomedical electrode line (stud/eyelet connectors "used in the manufacture of 3M Red Dot™ biomedical electrodes by Minnesota Mining and Manufacturing Company"). The claims (adhesive-backed electrode patch, connector stud, ionically-conductive adhesive strip, scrim) map directly onto that product family.
• Line of business: Diversified multinational manufacturer (industrial, safety, healthcare, consumer); biomedical electrodes were a 3M Health Care product line.
• Current status: Operating. 3M remains a publicly traded operating company. Note: 3M spun off its health-care business as Solventum effective 2024-04-01, and 3M Innovative Properties Company continues as a 3M subsidiary — but this patent lapsed in 2010, ~14 years before that spinoff, so the spinoff is irrelevant to this chain.

Assignment timeline

Only two recorded assignments exist. Both are inventor-to-company and internal-company transfers — there is no post-issuance transfer to any third party, LLC, or NPE.

• 1999-01-04 (executed) / recorded 1999-05-03 — Reel 009969/0556

  • Conveyance: Assignment of Assignors' Interest
  • Assignor: Nikolaus Loutis; Derek Wright; Paul Wiedenhaupt
  • Assignee: Minnesota Mining and Manufacturing Company
  • Correspondent: not verifiable in this session (USPTO Assignment Center field; see caveat above)
  • Context: Routine employee-to-employer assignment of the PCT application (US09/214,878, filed 1997-07-14) to 3M.

• 2002-02-06 (executed) / recorded 2002-02-26 — Reel 012652/0482

  • Conveyance: Assignment (corporate transfer)
  • Assignor: Minnesota Mining and Manufacturing Company
  • Assignee: 3M Innovative Properties Company (record text spells it "3M INNOVATIVE PROPERTIES COMANY")
  • Correspondent: not verifiable in this session
  • Context: Standard internal reorg — 3M's practice of vesting patent ownership in its captive IP subsidiary, 3M Innovative Properties Company. Patent issued 2002-07-02, i.e., after this transfer, which is why the front page names 3M Innovative Properties Co.

No further assignments are recorded. The Google Patents legal-event feed (which aggregates USPTO assignment records) shows no entries after 2002-02-26 — no security agreement, no merger, no license, no change of name, and no transfer out of the 3M family. The next events are purely maintenance-fee related: fee payment 2006-01-03, lapse for non-payment effective 2010-07-02 (LAPS 2010-07-02; FP recorded 2010-08-24).

Timeline diagram

timeline
    title Ownership of US 6415170
    1996 : UK priority application filed
    1997 : PCT filed by Minnesota Mining
    1999 : Inventors assign to Minnesota Mining
    2002 : Transfer to 3M Innovative Properties
    2002 : Patent issued
    2006 : Maintenance fee paid
    2010 : Lapsed for unpaid maintenance fees

NPE / troll-pattern signals

1. Shell-entity transfer — not present. The only post-inventor assignee is 3M Innovative Properties Company, the long-standing captive IP subsidiary of an operating manufacturer that practices the claims (Red Dot™ electrodes). No licensing-only LLC, no registered-agent address, no single-purpose Delaware/Texas LLC appears anywhere in the chain (reels 009969/0556 and 012652/0482).

2. Known asserter in the chain — not present. Neither Minnesota Mining and Manufacturing Company nor 3M Innovative Properties Company appears on any public NPE/asserter list (Acacia, Marathon, IV, IPNav, Wi-LAN, Conversant, Vringo, Innovatio, MPHJ, Round Rock, Spangenberg entities, etc.). 3M is a practicing operating company, and 3M Innovative Properties is its standard patent-holding arm used across thousands of 3M patents.

3. Repeat correspondent across the chain — unclear / unverifiable. Correspondent-of-record fields for reels 009969/0556 and 012652/0482 could not be retrieved in this session. No correspondent-based inference is made. (Both recordings, however, are ordinary 3M-house conveyances, so even if a single 3M paralegal or outside firm appears on both, it would reflect routine docketing, not an NPE pattern.)

4. Cascading transfers — not present. Exactly two conveyances, spaced three years apart (1999 and 2002), both within the 3M corporate family. No chained LLCs, no rapid-fire reassignments.

5. Pre-litigation transfer — not present. Independent litigation search found no suit naming US 6415170 at any time (see prior litigation summary); there is no assertion event for any transfer to have preceded.

6. Bankruptcy fire-sale — not present. 3M has never been in Chapter 7/11; the patent was never sold in any insolvency proceeding.

7. Privateering — not present. No transfer from 3M to any third-party enforcer, and no SEC/8-K disclosure of any such arrangement exists because none occurred.

8. Defensive aggregator (anti-NPE) — not present. The chain does not end at RPX, AST, LOT Network, Unified Patents, or OIN. It ends at 3M Innovative Properties Company, and the patent then died by non-payment of maintenance fees in 2010 — which neutralized it regardless.

Verdict

Defensive / non-asserting (with the caveat that the formal definition contemplates termination at a defensive aggregator; here the chain instead terminates at 3M's captive IP subsidiary — functionally the same outcome: no NPE, no assertion, patent neutralized).

The complete recorded chain is two benign conveyances — inventors to Minnesota Mining and Manufacturing (reel 009969/0556, recorded 1999-05-03) and an internal transfer to 3M Innovative Properties Company (reel 012652/0482, recorded 2002-02-26) — with no third-party transfer ever recorded and no litigation ever filed. The patent lapsed for unpaid maintenance fees effective 2010-07-02, consistent with a defensive/utility patent in a large operating-company portfolio that 3M chose not to maintain; there is zero evidence of shell-entity transfer, privateering, or assertion. Verification: https://assignmentcenter.uspto.gov/ (search "6415170") and the legal-events tab at https://patents.google.com/patent/US6415170/en.

Prior-Art Analysis for U.S. Patent 6,415,170 ("6415170" / US6415170B1)

1. USPTO database confirmation for the searched number

I searched for the identifier 6415170 (and its variants US6415170, 6,415,170) and confirmed the record is U.S. Patent 6,415,170 B1, "Biomedical electrode and method for its manufacture," 3M Innovative Properties Co. (orig. Minnesota Mining and Manufacturing), inventors Nikolaus Loutis, Derek Wright, Paul Wiedenhaupt. No similar-numbered patents were returned.

• USPTO application no.: 09/214,878 (national stage of PCT/US1997/012124)
• Filing date: 1997-07-14; Priority: GB 9625533.6 filed 1996-12-09
• Issue date: 2002-07-02; Status: Expired – Fee Related (lapsed 2010 for nonpayment of maintenance fees)
• Authoritative records: USPTO Patent Center / Patent Public Search (application 09/214,878); the citation list below is taken verbatim from the patent's own "Patent Citations (17)" table on the Google Patents record of US6415170B1, which mirrors the USPTO front-page references.

2. Statutory framework (pre-AIA § 102)

Because the application was filed before March 16, 2013, pre-AIA 35 U.S.C. § 102 governs. All 17 cited references were published between 1974 and 1995 — more than one year before both the US filing date (1997-07-14 → bar date 1996-07-14) and the UK priority date (1996-12-09 → bar date 1995-12-09). Accordingly, every cited reference is available as § 102(a) and § 102(b) prior art (and the US patents also as § 102(e) art), irrespective of which effective filing date is credited. The question is therefore purely whether any single reference discloses every element of a given claim, arranged as claimed.

Independent claims at issue: 1, 3, 5, 7, 19, 22 (claims 2, 8, 20 add that the two strips' nearest edges are substantially contiguous; claims 9–18 and 21–29 add dependent limitations). Their distinctive combination is: (i) a non-adhesive margin/tab; (ii) a connector stud with an electrode plate on the adhesive side and a head on the other side; (iii) a strip of ionically-conductive adhesive (ICA) running parallel to the margin, over the plate, with both the ICA strip and a parallel scrim strip at the ICA/PSA interface displaced toward the margin so that the nearest edges of both strips sit to one side of the plate; and (iv) for method claims 3/5, insertion into a pierced opening, claim 5 using a tubular-member/sleeve-assisted insertion.

Key finding up front: No single cited reference appears to disclose the entire combination (offset scrim strip + edge-to-edge or offset ICA strip + tab margin + one-piece stud in a pierced opening + specified edge-to-plate geometry). That is consistent with the patent issuing over these references. The closest single disclosures are the 3M retainer-sheet family (US 4,640,289 / US 4,727,881 / EP 0 142 372) and the 3M "biomedical electrode construction" family (US 5,215,087 / EP 0 360 496), the latter being the only cited reference that expressly teaches a scrim between a conductive adhesive and a skin adhesive.

3. Reference-by-reference analysis (from the 17 patent citations)

Note: EP 0 142 372 A1 is the counterpart of the US 4,640,289 / 4,727,881 family; EP 0 276 661 is the counterpart of US 4,938,219; EP 0 360 496 is the counterpart of US 5,215,087. Counterpart families are treated as one disclosure for § 102 purposes.

A. Anchoring-means prior art (cited in the '170 Background as ring/washer stud anchoring)

1. US 3,841,312 A — "Electrode arrangement"

• Consolidated Medical Equipment; filed 1973-03-29; published 1974-10-15.
• Description: Early ECG skin electrode in which the connector/terminal is anchored to the electrode assembly with a separate ring or washer, the very approach the '170 patent sought to avoid.
• § 102 potential: Does not disclose an ICA strip, a scrim at an adhesive interface, or a non-adhesive margin arrangement. Potentially anticipates: none of claims 1–29 standing alone; relevant only to the background problem of stud anchorage (relevant to claim 3's generic "inserting the stud into an opening in a backing" only in combination under § 103, not § 102).

2. US 4,117,846 A — "Skin conducting electrode and electrode assembly"

• Consolidated Medical Equipment; filed 1976-05-07; published 1978-10-03.
• Description: Skin-conducting electrode using washer-type securement of the connector to the adhesive pad (a pair of washers, per the later 3M/NDM descriptions of it).
• § 102 potential: Same as '312; no ICA/scrim/tab-margin teaching. Potentially anticipates: none of the independent claims alone.

3. US 4,352,359 A — "Biomedical electrode" (3M; explicitly discussed in the '170 Background)

• Minnesota Mining and Manufacturing; filed 1977-08-19; published 1982-10-05.
• Description: Electrode with a one-piece connector stud whose head is located in a punched aperture in a patch of adhesive tape; the tape overlies the upper surface of the stud and helps hold the electrode to the skin.
• § 102 potential: Discloses a one-piece stud in a backing opening with the plate/head on opposite sides (elements of claims 1/7/19/22(b); generic element of method claim 3). However, it uses a punched (not pierced) aperture, does not disclose the ICA strip over the plate, and has no scrim strip or offset geometry. Potentially anticipates: none of claims 1–29 alone; strongest against the preambular/stud elements and (in combination) against claim 3.

4. US 4,281,878 A — "Electrode structure for electrocardiograph and related physiological measurements and the like"

• Vaughn Corporation; filed 1979-08-17; published 1981-08-11.
• Description: ECG electrode structure; cited as general background on electrode construction/attachment.
• § 102 potential: No indication it teaches the stud + offset ICA/scrim strip combination. Potentially anticipates: none of the independent claims alone.

5. US 4,441,500 A — "EKG Electrode"

• Ferris Manufacturing Corp.; filed 1980-04-17; published 1984-04-10.
• Description: EKG electrode construction with conductive medium and skin attachment.
• § 102 potential: General background; no evidence of the offset-scrim/ICA-strip geometry. Potentially anticipates: none of the independent claims alone.

B. 3M retainer-sheet one-piece-terminal family (the "closest prior art" described in the '170 Background)

6. US 4,640,289 A — "Biomedical electrode" (3M; explicitly discussed in the '170 Background)

• Minnesota Mining and Manufacturing; filed 1983-11-14; published 1987-02-03.
• Description: Biomedical electrode with a one-piece terminal member located in a punched aperture in adhesive tape, a conformable ionically conductive layer under the terminal base, and a retainer sheet that positionally confines the terminal without washers. The specification discloses an automated manufacturing line (die-cut apertures, vacuum placement of terminals, lamination of the conductive layer) and a tab formed in a margin of the adhesive tape for removal from the liner/skin.
• § 102 potential: Reads on many elements of claims 1/7/19/22 (a)–(c) (tabbed adhesive backing, one-piece terminal with base/plate and post/head, ionically conductive medium over the plate) and on the automated insertion concept of method claims 3/5. Missing: the strip of ICA extending across the adhesive side over the plate as a strip with a scrim at the ICA/PSA interface; the displacement of both strips toward the tab margin with their nearest edges to one side of the plate (instead, a full retainer sheet surrounds the terminal); and pierced-opening/sleeve insertion. Potentially anticipates: none of claims 1–29 alone, but it is the reference the examiner would use as primary for § 103 against claims 1, 7, 19 and 22.

7. US 4,727,881 A — "Biomedical electrode" (3M; family member of '289)

• Minnesota Mining and Manufacturing; filed 1983-11-14; published 1988-03-01.
• Description: Same electrode family as '289; adds a metal layer and expressly contemplates "a wide variety of ionically conductive mediums including conductive adhesives."
• § 102 potential: Slightly stronger than '289 on the ICA-over-plate element if the conductive medium is applied as a strip. Still missing the offset scrim strip and the strip-edge/plate geometry of claims 1, 7, 19, 22. Potentially anticipates: none of the independent claims alone.

8. EP 0 142 372 A1 — "Biomedical electrode" (3M; counterpart of '289/'881)

• Filed 1983-11-14; published 1985-05-22.
• Description: European counterpart disclosing the same retainer-sheet electrode family; qualifies as a foreign printed publication under § 102.
• § 102 potential: Same disclosure as items 6–7. Potentially anticipates: none of the independent claims alone.

C. Fukuda Denshi family

9. EP 0 276 661 A2 — "Electrocardiographic electrode"

• Fukuda Denshi Co., Ltd.; filed 1987-01-16; published 1988-08-03.
• Description: ECG electrode construction (a flat, low-profile electrode with conductive gel/adhesive and skin adhesive).
• § 102 potential: Without the full text I cannot confirm whether it shows a scrim-reinforced, tab-offset ICA strip; the cited record gives no indication it teaches the offset-scrim arrangement. Potentially anticipates: none of the independent claims with high confidence. (EP 0 276 661 B1, also listed, is the granted version of the same disclosure.)

10. US 4,938,219 A — "Electrocardiographic electrode"

• Fukuda Denshi Co., Ltd.; filed 1987-01-16; published 1990-07-03 (US counterpart of EP '661).
• Description/§ 102 potential: Same disclosure as EP '661. Potentially anticipates: none of the independent claims alone.

D. 3M "biomedical electrode construction" family — the only cited art expressly teaching a scrim between conductive and skin adhesives

11. US 5,215,087 A — "Biomedical electrode construction" (3M)

• Minnesota Mining and Manufacturing; filed 1988-09-22; published 1993-06-01.
• Description: A flat, flexible biomedical electrode with an insulator construction (backing) carrying a skin (pressure-sensitive) adhesive on one side, a flat conductor member having a pad portion on the skin side and a tab portion on the opposite side, and a layer of conductive adhesive over the pad. Critically, the specification states that "a scrim may be positioned between the conductive adhesive and the non-conductive skin adhesive, to facilitate adherence." It also discloses carbon-containing conductive webs and a release liner.
• § 102 potential: This is the single most relevant reference to the scrim-at-the-interface element of claims 1, 7, 19 and 22 (element (d)). Missing, however: the conductive adhesive arranged as a strip extending across the backing from edge to edge (claim 1) or as a strip displaced toward the non-adhesive margin with both strips' nearest edges terminating to one side of the electrode plate — in '087 the conductive adhesive is a "field" completely surrounded by skin adhesive, not an offset strip ending beside the plate; nor does it disclose a stud-in-pierced-opening or sleeve insertion. Potentially anticipates: none of claims 1–29 alone, but it is the strongest § 102 candidate for the scrim element and the most likely primary reference (with '289 or '945) for a § 103 rejection of claims 1, 7, 19, 22.

12. EP 0 360 496 A1 — "Biomedical electrode construction" (3M; counterpart of '087)

• Filed 1988-09-22; published 1990-03-28 (EP 0 360 496 B1 also cited — granted version).
• Description/§ 102 potential: Same disclosure as US 5,215,087. Potentially anticipates: none of the independent claims alone, for the same reasons.

E. Ludlow "dry-edge" printed-electrode art

13. WO 1993/000857 A1 — "Biomedical electrode"

• Ludlow Corporation; filed 1991-07-12; published 1993-01-21.
• Description: Low-cost disposable ECG electrode made in a single assembly pass: a non-conductive backing with a printed conductive ink pattern (Ag/AgCl or blended carbon) and a conductive-adhesive electrolyte layer coated directly onto the patterned surface leaving a "dry edge for a connector," plus a release liner. Emphasizes pattern-coating to control electrode impedance.
• § 102 potential: Relevant to pattern/strip coating of conductive adhesive and to leaving a non-adhesive/dry margin, but it has no connector stud (the connector attaches to printed ink, not to a stud's head) and no scrim. Because claims 1, 7, 19, 22 all require a connector stud with plate/head on opposite sides, and claims 3/5 require stud insertion into a pierced opening, '085 does not anticipate any independent claim; it is combination art for the ICA-strip and margin elements.

F. Adhesive-composition and terminal-anchoring art

14. US 5,438,988 A — "Pressure-sensitive poly(N-vinyl lactam) adhesive composition and biomedical electrodes using same" (3M)

• Filed 1991-11-15; published 1995-08-08.
• Description: Pressure-sensitive adhesive compositions (poly(N-vinyl lactam)-based), useful as ionically conductive adhesives in biomedical electrodes; the '170 specification cites it (with other references) as describing ionically-conductive adhesives suitable for its ICA strip.
• § 102 potential: A composition/utility reference; it does not disclose the structural combination of the '170 claims. Potentially anticipates: none of the apparatus/method claims 1–29 (relevant only to the nature of element (c)'s adhesive).

15. US 5,406,945 A — "Biomedical electrode having a secured one-piece conductive terminal"

• NDM Acquisition Corp.; filed 1993-05-24; published 1995-04-18.
• Description: Disposable electrode with a one-piece conductive terminal (base integrally joined to a stud member) secured without washers or retaining rings by sandwiching an adhesive-coated anchoring layer between a gel support layer and a reinforcing strip/top layer. The gel is a moist hydrogel (polyhydric alcohol/isocyanate-prepolymer/polyamine/NaCl) selected for non-adherence to skin, and an optional release tab 46 aids peeling from the liner.
• § 102 potential: Reads on claims 1/7/19/22 elements (a) and (b) — adhesive-backed construction, one-piece terminal with base (plate) and stud (head), tab margin — and is strong art on one-piece-terminal anchorage without separate washers. Missing: an ICA strip over the plate combined with a scrim strip at the ICA/PSA interface displaced toward the tab margin with the strips' nearest edges to one side of the plate (the gel is a full hydrogel layer, not a tab-offset ICA strip with edge-to-edge or offset geometry), and the pierced-opening/sleeve insertion of method claims 3/5. Potentially anticipates: none of claims 1–29 alone.

4. Ranking of most relevant prior art

5. Bottom line on § 102 anticipation

• Claim 1, 7, 19, 22 (apparatus): No single cited reference discloses the combination of a tab/non-adhesive-margin backing, a stud whose plate and head lie on opposite sides, an ICA strip over the plate, and a scrim strip at the ICA/PSA interface that is displaced toward the margin with both strips' nearest edges terminating to one side of the electrode plate. US 5,215,087 supplies the scrim-at-interface teaching but surrounds the conductive adhesive with skin adhesive rather than offsetting both strips beside the plate; US 4,640,289/4,727,881 and US 5,406,945 supply the one-piece-terminal/tab constructions but lack the offset scrim strip. Therefore no cited reference likely anticipates these claims; the art would need to be combined under § 103.
• Claim 3 and 5 (methods): The generic insertion step of claim 3 is reminiscent of US 4,352,359 (punched aperture) and US 4,640,289 (die-cut aperture with vacuum placement), but claim 3 requires a pierced opening plus a scrim strip to one side of the plate's center, and claim 5 requires the distinctive tubular-member/sleeve-assisted, head-first insertion — a mechanism not disclosed in any cited reference. No cited reference alone anticipates claims 3 or 5.

6. Caveats and verification limits

• Descriptions of US 3,841,312; US 4,117,846; US 4,352,359; US 4,640,289; US 4,727,881; US 5,215,087; US 5,406,945; and WO 93/00857 were verified against full-text search results (Google Patents / FreePatentsOnline / USPTO report mirrors). The EP and foreign-family descriptions rest on the cited titles, dates, and their verified US counterparts; I could not retrieve complete texts of EP 0 142 372, EP 0 276 661, or EP 0 360 496 in this session, so their "potentially anticipates" conclusions are drawn from their US counterparts.
• "Potentially anticipates" here means the reference appears to disclose all elements of the indicated claim as a matter of claim construction; it is an analyst's assessment, not a determination that anticipation would be found — no single reference is assessed as actually anticipating any independent claim.
• Because the patent lapsed in 2010 for nonpayment of maintenance fees, these § 102/103 questions are now of historical/technical interest only; no enforcement is possible.

I'll verify the teachings of the key cited references before constructing the obviousness analysis.

I have good detail on 4,640,289, 5,215,087, and 5,406,945. Now let me verify the remaining key references.

I have reached the limit of available searches, but I have sufficient verified detail on the central references (from the patent's own record, its Background section, and the search results retrieved above) to construct the § 103 analysis. Where a reference's detailed text was not independently verified this session, I say so explicitly.

Obviousness Analysis — US 6,415,170 B1 ("Biomedical electrode and method for its manufacture")

1. Scope of the claims under analysis

The independent claims relevant to § 103 are the apparatus claims 1, 7, 19, 22 and the method claims 3 and 5 (claim 3 and dependent claim 6 cover a pierced-opening insertion; claim 5 and dependent claim 6 cover a tubular-sleeve-assisted insertion into a pierced or punched opening). The remaining claims are dependent.

Stripped to their operative elements, the apparatus claims require:

The method claims add: (3) insertion of a one-piece stud into a pierced opening + scrim strip to one side of the plate center; (5) forming an opening, inserting a tubular member through it, and seating the stud head-first in the sleeve end so the stud is drawn into the opening.

The patent's own statement of the problem (Background and Summary) frames the inventive goals: lower-cost, simpler manufacture of biomedical electrodes; secure anchoring of a one-piece stud; and preservation of the bond between the ionically-conductive adhesive and the PSA at the tab-side edge during liner removal and skin removal, using a scrim strip deliberately offset toward the pull-tab margin.

2. Person of ordinary skill in the art (POSITA)

A POSITA would be an engineer or polymer scientist with a B.S./equivalent in mechanical, chemical, or materials engineering and 2–4 years designing disposable medical electrodes or skin-contact medical devices: familiar with PSA and ionically-conductive hydrogel adhesives, die-cutting/laminating web converting, snap-stud/terminal anchoring, and electrode manufacturing economics. This profile matters because the disposability and cost pressures in this field make component reduction and process simplification strong, well-documented motivations (see the Background of both US 4,640,289 and US 5,406,945, which expressly praise eliminating washers/retaining rings and two-piece studs "to decrease material requirements and manufacturing costs").

3. Prior-art disclosures relevant to the combination (from the patent record)

All references below were cited on the face of US 6,415,170 and/or discussed in its specification, and all issued/published before the 1996–1997 priority/filing dates.

US 4,352,359 (3M; 1982) — "Biomedical electrode." The patent's own Background describes it: a one-piece stud whose head portion sits in a punched aperture in a patch of adhesive tape; the tape overlies the upper surface of the stud and holds the electrode to the skin; a dry hydrophilic conductive polymer is on the body-contact side. Teaches: one-piece connector stud + adhesive-coated backing + skin-side conductive medium — the basic architecture of the claims. (Verified via record Background; Google Patents snippet confirms the hydrophilic conductive polymer, dry-electrode teaching.)

US 4,640,289 (3M; 1987) — "Biomedical electrode." Verified in detail this session. Teaches: (i) a one-piece terminal member (base + upstanding post) anchored without washers; (ii) an ionically-conductive layer in contact with the base underside; (iii) a retainer sheet with an aperture receiving the post, confining the terminal; (iv) an optional medical tape with a pressure-sensitive adhesive coating extending beyond the conductive layer to secure the electrode to skin; (v) protective release liners; and (vi) an automated manufacturing method, including die-cutting apertures, vacuum placement of terminal members, and controlled-depth die cutting that forms a tab (74) in a margin of the adhesive tape to facilitate removal from the liner. This is the closest single reference to the assembly and handling features: one-piece terminal, PSA tape margin with tab, release liner, conductive layer, and automated manufacture.

US 5,215,087 (3M; 1993) — "Biomedical electrode construction." Verified this session, including the specification's express statement: "a scrim may be positioned between the conductive adhesive and the non-conductive skin adhesive, to facilitate adherence. That is, a thin layer of material may be utilized as the bridge between the conductive adhesive and the non-conductive skin adhesive." The reference also shows fields of conductive adhesive and skin adhesive on an insulator construction with a conductor pad portion on one side and a tab portion on the other, and release liners. Teaches the scrim-at-the-adhesive-interface feature and the two-adhesive (conductive + skin) layout — the two most structurally important features of claims 1, 7, 19, and 22 other than the offset geometry.

US 5,406,945 (NDM Acquisition Corp.; 1995) — "Biomedical electrode having a secured one-piece conductive terminal." Verified this session. Teaches: a one-piece terminal (base + integral stud) secured without washers/retaining rings, an electrolytic gel layer, an anchoring layer with a perforated portion, a reinforcing strip with an opening sized to the stud that holds the base against the anchoring layer, and a top layer with a patient-contact adhesive coating whose ends secure to the patient; an optional release tab; and the background teaching that the known alternatives were two-piece stud-and-eyelet snap connectors (expensive, corrosion-prone) or washers/rings (complex). Its Background mirrors — and therefore evidences the known motivation for — the '170 patent's cost-reduction goal with one-piece studs.

US 3,841,312 and US 4,117,846 (both discussed in the '170 Background): biomedical electrodes using a separate ring or washer to anchor the connector stud in the backing. These evidence the known concept of clamping backing material between a flange-like projection of the stud and the electrode plate (the space-6 capture geometry of the '170 stud) and the recognized cost/complexity problem with separate anchoring rings — the exact problem the '170 flange-on-stem design solves.

US 5,133,356 (3M; 1992) — "Biomedical electrode having centrally-positioned tab construction." Listed in the record's Similar Documents and consistent with the 3M "Red Dot"-family tab art. (Detailed text not independently re-verified this session; relied on for the well-settled teaching that tab placement and peel mechanics drive electrode margin design.)

Ionically-conductive adhesive art incorporated by reference in the '170 specification: US 4,524,087; 4,539,996; 4,848,353; 5,225,473; 5,276,079; 5,338,490; 5,362,420; 5,385,679; WO 95/20634; WO 94/12585; and WO 96/15715 (pattern/strip coating of conductive adhesive). These establish that strip-form, pre-cured, ionically-conductive pressure-sensitive adhesives laminated onto a foam backing were routine by 1996. The PSA art (US 2,973,826; Re 24,906; Re 33,353; 3,389,827; 4,112,213; 4,310,509; 4,323,557; 4,732,808; 4,917,928; 4,917,929; EP 0,051,935) establishes the same for acrylate PSA backings.

EP 0,276,661 (Fukuda Denshi; 1988) and US 4,938,219; EP 0,360,496 / US 5,215,087 (3M); EP 0,142,237 / US 4,721,881 (3M); WO 93/00857 (Ludlow); US 4,382,878 (Vaughn). These additional ECG-electrode references on the face of the patent collectively show the crowded field: foam-backed snap electrodes, conductive-gel windows over a terminal plate, peripheral PSA, and release liners. (Individual texts not re-verified this session; they are relied on only cumulatively.)

4. Primary obviousness combinations and the § 103 case

Combination A — Apparatus claims 1, 7, 19, 22: US 4,640,289 in view of US 5,215,087 (and US 4,352,359 / US 5,406,945 for the stud)

Mapping claim 1 onto US 4,640,289 alone:

• Backing/PSA + non-adhesive margin/tab: the adhesive tape margin with tab 74 (formed by controlled-depth die cutting) ✓
• One-piece terminal with plate (base 20) on the skin side and post 26 on the connector side ✓
• Ionically-conductive strip over the plate: the conductive layer 16 in contact with the base underside ✓ (although in 4,640,289 the conductive layer is a patch, not an edge-to-edge strip)
• Missing: the express strip geometry parallel to the margin, the offset of the conductive strip and scrim toward the tab margin with both near edges to one side of the plate, and the scrim.

Where the missing pieces come from:

• Scrim at the adhesive interface: US 5,215,087 explicitly teaches "a scrim may be positioned between the conductive adhesive and the non-conductive skin adhesive, to facilitate adherence ... as the bridge between the conductive adhesive and the non-conductive skin adhesive." A POSITA combining 4,640,289 (PSA tape + conductive layer + tab margin) with 5,215,087 (same two-adhesive architecture plus a bridging scrim) would have had express direction to put a scrim strip at the interface. Both are 3M electrodes in the same product family; the '170 specification's own ionically-conductive and PSA adhesive lists overlap heavily with these references.
• Strip geometry (edge-to-edge, parallel to margin): Strip- and pattern-coated adhesive lanes are taught by WO 96/15715 (cited in the '170 specification for pattern coating) and were conventional in web converting; converting 4,640,289's discrete conductive patch into a continuous transverse strip is a routine manufacturing choice, not a new principle. The claim's "generally parallel to the non-adhesive margin" is simply a lane laid down parallel to the tab edge in a web process — the arrangement that minimizes scrap in the automated die-cutting line 4,640,289 already teaches.
• Offset of the strips toward the tab margin; near edges of both strips to one side of the plate: This is the most claim-specific geometry. The '170 specification itself states the purpose: the scrim must maintain the bond between the conductive adhesive and the PSA "in the vicinity of the electrode plate ... particularly when the electrode is removed either from the liner material or, after use, from the patient's skin using the tab." That is a known peel-mechanics problem in a known location: the tab (4,640,289; 5,133,356; 5,406,945's release tab) deliberately concentrates removal force at the margin, so the interface stress is highest at the tab-side edge of the conductive strip. Once the POSITA knows (from 5,215,087) that a scrim is the standard remedy for conductive-adhesive/PSA delamination, selecting the tab-side edge — the edge subjected to the peeling load — as the place to reinforce is an obvious, result-effective use of the known means at the known point of failure. The '170 patent itself describes the strip widths as being "as narrow as possible consistent with reliability," i.e., a cost-minimization optimization; restricting the scrim to the loaded edge (and, in the FIG. 7/claim 22 form, letting it extend between the PSA and the plate) is precisely the sort of dimensioning and placement optimization a POSITA performs as a matter of ordinary skill. Dependent claims 2, 8, 20 (contiguous edges), 9–10, 19 (scrim to one side of plate center), 11, 22 (scrim between PSA and plate), 12–13, 23–24 (non-extension beyond the remote plate edge; coextensive strips), 14–16, 25–27 (rectangular backing; lamination of pre-cured strip), 17–18, 28–29 (one-piece stud in pierced hole; liner) each merely quantify or conventionalize the same combination — e.g., "pierced" vs. "punched" holes is discussed as an alternative in the '170 text itself, and pre-cured adhesive lamination is routine converting practice taught by the cited adhesive art.

Mapping claims 7, 19, 22: Claim 7's added recital that the ionic strip itself is displaced toward the margin is no more than a description of the same offset geometry from the perspective of the other strip (the '170 figures show both strips co-located, and dependent claim 13/24 recite them as "substantially co-extensive"). Claim 19's "scrim to one side of the center of the plate" is the necessary consequence of the same offset — if the scrim's near edge is to one side of the plate and the strip does not cross the plate's center, the scrim is necessarily on one side of the center; claim 9 makes that explicit. Claim 22's "scrim extends between the PSA and the electrode plate" is disclosed in the '170 text itself as an alternative to the FIG. 3–6 form ("A scrim strip which is slightly wider ... could ... be arranged to extend over, rather than under, the electrode plate ... provided that it is not so wide that it would impair the electrical connection"), and 5,215,087's scrim is likewise described as interposed between the two adhesives in the region of the conductor. Nothing in claims 7, 19, or 22 rises above the level of arranging known elements (two adhesives, scrim, plate, tab margin) in a way whose location is dictated by the known failure mode.

Combination B — One-piece-stud anchoring features: US 4,352,359 and/or US 5,406,945 in view of US 3,841,312 / US 4,117,846

The apparatus claims require a connector stud located in the backing with the plate and head on opposite sides — they do not on their face require the specific flange/stem/space-6 geometry or a pierced hole (those appear in dependent claims 17, 28 and the method claims). But to the extent the '170 stud design (integral flange spaced from the plate, capturing the backing in space 6) is read into the claims:

• US 4,352,359 already places a one-piece stud in an aperture in an adhesive tape.
• US 3,841,312 / US 4,117,846 teach that backing is anchored by clamping it between a plate and a separate ring — i.e., the functional equivalent of the '170 flange capture, but as a separate part.
• US 5,406,945 teaches eliminating the separate washer/ring by giving the one-piece terminal a base held by a reinforcing strip and adhesive top layer, and explicitly motivates the design by manufacturing cost.
  Merging the one-piece stud of 4,352,359/5,406,945 with the integral capture geometry that US 3,841,312/4,117,846 achieved with a separate washer — making the ring an integral flange on the stud — is the classic substitution of an integral part for a separate fastener to save a part and an assembly step, an approach 5,406,945 (and 4,640,289) expressly praise. The flange-diameter/head-diameter ratios in the specification (at least 1.3×, preferably 1.5×) are routine engineering sizing for pull-out resistance.

Combination C — Method claims 3 and 5

• Claim 3 (pierced opening + scrim to one side of plate center): US 4,640,289 already discloses the automated counterpart: forming apertures (there by die-cutting/punching), placing the one-piece terminal, laminating, and die-cutting tabs. Substituting piercing for punching an opening in a foam backing was, on this record, an acknowledged alternative — the '170 specification itself says the opening "is preferably a pierced opening but it could, alternatively, be a punched opening" — and piercing of foam webs was conventional. The scrim element is Combination A's scrim, now placed relative to the plate center as in claim 19. A POSITA combining 4,640,289's automated assembly with 5,215,087's scrim would arrive at claim 3 with a reasonable expectation of success: the components are identical in kind, and the process steps are the same converting operations (pierce, place, laminate, die-cut).
• Claim 5 (tubular-sleeve-assisted stud insertion): The claimed sequence — form opening; insert a tubular member through it; place the stud head-first into the sleeve end from the opposite side; withdraw the sleeve to draw the stud into the opening — is a mechanical analog of well-known snap-fastener assembly tooling (the same tooling art that inserts stud-and-eyelet connectors and grommets, where a hollow punch/sleeve holds the work open while the fastener is seated). The flange-engages-sleeve-end detail is dictated by the need to keep the stud from falling through the sleeve — a design choice, not an invention. Given 4,640,289's automated terminal-placement station and the recognized difficulty (stated in the '170 Background, quoting the known art) of inserting a large-flange one-piece stud into a small opening, using a sleeved piercing tool to hold the hole open while seating the stud is the obvious mechanical expedient — the same function a conventional eyelet-setting tool performs in the two-piece stud/eyelet assembly US 5,406,945 describes as standard. Claim 6's punched-opening alternative is expressly within the '170 text as an alternative, further confirming interchangeability.

5. Motivation to combine — summary

1. Same field and overlapping assignees/product lines: Most primary references are 3M disposable ECG electrodes (4,352,359; 4,640,289; 5,215,087; 5,133,356); the '170 patent is a 3M continuation of that same Red Dot-family design space. A POSITA designing a low-cost 3M-style tab electrode would naturally consult the house art and the cited NDM art.
2. Shared, well-documented problem: Cost and part-count reduction for one-piece-stud electrodes (5,406,945 Background; 4,640,289 Background; '170 Background) plus prevention of terminal pull-out (4,640,289 retainer sheet; 3,841,312/4,117,846 washers; 5,406,945 reinforcing strip). The '170 solution — an integral flange and pierced-hole capture — is the obvious endpoint of that progression.
3. Known failure mode at a known location: Tab-driven removal (4,640,289 tabs; 5,133,356; 5,406,945 release tab) concentrates peel stress at the margin-side edge of the gel window; scrim bridging of the conductive-adhesive/skin-adhesive interface was already taught for exactly the purpose of maintaining adherence (5,215,087). Placing the scrim where the peel stress is highest — toward the tab margin, one side of the plate — is applying a known remedy to a known stress concentration. The '170 specification's own language confirms this is what the offset accomplishes.
4. Routine optimization: "As narrow as possible consistent with reliability" (the '170 specification) and strip coating/laminating pre-cured adhesive lanes (WO 96/15715 and the cited ionic-adhesive art) are standard web-converting economics. Narrowing the scrim to the loaded edge and aligning both strip edges at one side of the plate are predictable dimensional choices, with no unexpected result on this record.
5. Reasonable expectation of success: Every element of claims 1, 7, 19, and 22 existed in the cited art in functional form; the combination uses each element in its known manner for its known purpose, yielding a predictable tabbed electrode with reinforced gel-window adhesion. Under the KSR framework (design incentives and known interchangeability), that is the paradigm of obviousness.

6. Claim-by-claim conclusion

The strongest independent claims on validity are claims 1 and 7, but even they reduce to (i) a known tabbed one-piece-stud electrode (4,640,289), (ii) a known scrim bridging layer between conductive and skin adhesives (5,215,087), and (iii) a known strip-coating/laminating process, with the only arguable point of novelty — offsetting both strips toward the tab margin — being a location choice dictated by the known peel-failure mode at the tab edge. That is a fact-intensive but ultimately conventional § 103 case.

7. Counterarguments a patent owner would raise (and their weaknesses)

• "No reference discloses the offset." True literally, but obviousness does not require a single reference disclosing the offset; the offset is the routine consequence of placing the known scrim-reinforcement where the known tab-removal peel load acts. The '170 specification itself concedes the strips should be as narrow as possible, i.e., the design is a cost/performance optimization.
• "Scrim in 5,215,087 is not offset and is coextensive with the gel field." The '170 patent itself discloses both coextensive (FIG. 6) and reduced-width (FIG. 7) scrim embodiments, confirming that width/placement variation was understood to be a matter of ordinary design choice within the same inventive concept.
• "Pierced openings with large flanges were hard to insert — that is why the sleeve was needed." The difficulty is admitted in the Background as a known problem of one-piece studs; solving a known problem with a known mechanical expedient (sleeved tooling) is not inventive.
• Secondary considerations: This record contains no evidence of long-felt need, copying, commercial success, or unexpected results tied to the offset geometry. The prior summary noted the patent lapsed for nonpayment of maintenance fees in 2010 — no objective indicia are on file. Absent such evidence, the prima facie case stands.

8. Caveats on evidentiary limits

• Reference texts for US 5,133,356, US 4,721,881, EP 0,142,372, EP 0,276,661/US 4,938,219, WO 93/00857, and US 4,382,878 were not independently re-verified this session (I hit the search-step limit). They are relied on only cumulatively and for their titles/assignees as shown on the face of the '170 record; the analysis above does not depend on any single unverified disclosure.
• US 4,640,289, US 5,215,087, US 5,406,945, and US 4,352,359 teachings were verified against live search results and/or the '170 specification's own Background, which is authoritative for how the applicants characterized them.
• The § 103 analysis is technical and historical (as of the 1996–1997 filing); it is independent of the patent's expired/lapsed enforcement status and of any litigation posture.

Bottom line: On the cited prior art, the apparatus claims (1, 7, 19, 22 and their dependents) would most likely be held obvious as a combination of US 4,640,289 (or 4,352,359) with US 5,215,087's scrim-between-adhesives teaching, applied at the tab-side edge where the peel load (tab art of 4,640,289/5,133,356/5,406,945) is concentrated; the method claims (3, 5, 6) would most likely be held obvious over 4,640,289's automated assembly method combined with conventional sleeved fastener-seating tooling, with pierced/punched hole selection being an acknowledged design alternative.